Octavio Galindo-Hernández

10PUBLICATIONS
21CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 27, 2026
Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation.

|Jan 08, 2025
Development of Liver-Targeting αVβ5+ Exosomes as Anti-TGF-β Nanocarriers for the Treatment of the Pre-Metastatic Niche.

Paloma Acosta Montaño, Eréndira Olvera Félix, Veronica Castro Flores

|Sep 28, 2024
Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Angel Pulido-Capiz, Brenda Chimal-Vega, Luis Pablo Avila-Barrientos

|Dec 23, 2023
Resistin Induces Migration and Invasion in PC3 Prostate Cancer Cells: Role of Extracellular Vesicles.

Mario Israel Oregel-Cortez, Héctor Frayde-Gómez, Georgina Quintana-González

|Jun 10, 2023
A Triazaspirane Derivative Inhibits Migration and Invasion in PC3 Prostate Cancer Cells.

Javier de Jesús Vasconcelos-Ulloa, Victor García-González, Benjamín Valdez-Salas

|Dec 23, 2022
eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.

Alina González-Ortiz, Angel Pulido-Capiz, César Y Castañeda-Sánchez

Pageof 2

Frequent Collaborators

8 joint publications

Victor García-González

5 joint publications

Raúl Díaz-Molina

3 joint publications

Ángel Pulido-Capiz

3 joint publications

Nicolás Serafín-Higuera